Systemic bone loss can occur in psoriatic arthritis, but it doesn’t always show up using traditional scanning methods, new research finds.
Evidence-based medicine and patient input needed in prescribing bisphosphonates for osteoporosis.
This is the latest sortie in the war between over- and under-treatment of osteoporosis.
New study results shed light on questions about the effect of combining drugs to treat osteoporosis and what happens after a switch from one drug to another.
(CCR 2015) A number of new osteoporosis treatments are on the near horizon, drawing on a new understanding of bone biology, as described by a speaker at the Clinical Congress of Rheumatology.
A new study suggests the importance of evaluating the vitamin D3 status and screening for comorbid conditions in patients with psoriasis or psoriatic arthritis.
Three eminent rheumatologists have posted their comprehensive textbook of rheumatology online, open-access and free. They are calling it Rheumaknowledgy.
A Miami rheumatologist tells why he has donated $1 million to offer his colleagues in community practice the chance to pursue their own clinical theories.
Antinuclear antibody testing and DEXA both appear on a new Canadian list of rheumatology tests to avoid and on a similar 2013 list from the American College of Rheumatology. There are interesting differences in the other 3 choices.
New data boosts confidence in drug therapies for osteoporosis, but more research in older adults is required.